{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T12:10:09Z","timestamp":1750421409390,"version":"3.41.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thoracic.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thoracic Surgery Clinics"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.thorsurg.2024.11.010","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T05:35:22Z","timestamp":1734068122000},"page":"169-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of Metastasectomy for Tissue Acquisition for Tumor-Infiltrating Lymphocyte Harvest and Biomarker\/Genomic Testing"],"prefix":"10.1016","volume":"35","author":[{"given":"Kevin","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian C.","family":"Bostock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.thorsurg.2024.11.010_bib1","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM198812223192527","article-title":"Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. a preliminary report","volume":"319","author":"Rosenberg","year":"1988","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.thorsurg.2024.11.010_bib2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ccell.2020.07.004","article-title":"Clinical challenges of immune checkpoint inhibitors","volume":"38","author":"de Miguel","year":"2020","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.thorsurg.2024.11.010_bib3","doi-asserted-by":"crossref","first-page":"e2200204","DOI":"10.1002\/bies.202200204","article-title":"Tumor-infiltrating lymphocyte therapy: clinical aspects and future developments in this breakthrough cancer treatment","volume":"45","author":"Lee","year":"2023","journal-title":"BioEssays News Rev Mol Cell Dev Biol"},{"issue":"Suppl 2","key":"10.1016\/j.thorsurg.2024.11.010_bib4","article-title":"492 Phase 2 efficacy and safety of autologous tumor-infiltrating lymphocyte (TIL) cell therapy in combination with pembrolizumab in immune checkpoint inhibitor-na\u00efve patients with advanced cancers","volume":"9","author":"O\u2019Malley","year":"2021","journal-title":"J\u00a0Immunother Cancer"},{"issue":"12","key":"10.1016\/j.thorsurg.2024.11.010_bib5","doi-asserted-by":"crossref","first-page":"e005755","DOI":"10.1136\/jitc-2022-005755","volume":"10","author":"Chesney","year":"2022","journal-title":"J\u00a0Immunother Cancer"},{"issue":"8","key":"10.1016\/j.thorsurg.2024.11.010_bib6","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/s41591-021-01462-y","article-title":"Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial","volume":"27","author":"Creelan","year":"2021","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.thorsurg.2024.11.010_bib7","first-page":"1934","article-title":"Use of adoptive transfer of tumor-infiltrating lymphocytes alone or in combination with cisplatin-containing chemotherapy in patients with epithelial ovarian cancer","volume":"51","author":"Aoki","year":"1991","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.thorsurg.2024.11.010_bib8","doi-asserted-by":"crossref","first-page":"e1502905","DOI":"10.1080\/2162402X.2018.1502905","article-title":"Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study","volume":"7","author":"Pedersen","year":"2018","journal-title":"OncoImmunology"},{"issue":"16_suppl","key":"10.1016\/j.thorsurg.2024.11.010_bib9","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1200\/JCO.2022.40.16_suppl.2536","article-title":"Efficacy and safety of autologous expanded tumor infiltrating lymphocytes (TILs) in multiple solid tumors","volume":"40","author":"Amaria","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"journal-title":"J\u00a0Immunol Res","article-title":"TILs and anti-PD1 therapy: an alternative combination therapy for PDL1 negative metastatic cervical cancer\u00a0- yin","year":"2020","key":"10.1016\/j.thorsurg.2024.11.010_bib10"},{"journal-title":"Clin Cancer Res","article-title":"A\u00a0phase II study of tumor-infiltrating lymphocyte therapy for human papillomavirus\u2013associated epithelial cancers","year":"2019","key":"10.1016\/j.thorsurg.2024.11.010_bib12"},{"journal-title":"J\u00a0Clin Oncol","article-title":"Breast cancers are immunogenic: immunologic analyses and a phase II pilot clinical trial using mutation-reactive autologous lymphocytes","year":"2022","key":"10.1016\/j.thorsurg.2024.11.010_bib13"},{"journal-title":"Clinical Cancer Research","article-title":"Prospective analysis of adoptive TIL therapy in patients with metastatic melanoma: response, impact of anti-CTLA4, and biomarkers to predict clinical outcome","year":"2018","key":"10.1016\/j.thorsurg.2024.11.010_bib14"},{"issue":"5","key":"10.1016\/j.thorsurg.2024.11.010_bib15","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/14712598.2022.2064711","article-title":"Tumor-infiltrating lymphocytes for adoptive cell therapy: recent advances, challenges, and future directions","volume":"22","author":"Granh\u00f8j","year":"2022","journal-title":"Expet Opin Biol Ther"},{"issue":"12_Supplement","key":"10.1016\/j.thorsurg.2024.11.010_bib17","doi-asserted-by":"crossref","first-page":"CT130","DOI":"10.1158\/1538-7445.AM2022-CT130","article-title":"Abstract CT130: trial in progress: a phase 2 multicenter study (IOV-LUN-202) of autologous tumor-infiltrating lymphocyte (TIL) cell therapy (LN-145) in patients with metastatic non-small cell lung cancer (mNSCLC)","volume":"82","author":"Chesney","year":"2022","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.thorsurg.2024.11.010_bib19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41379-018-0113-8","article-title":"Presence of tertiary lymphoid structures determines the level of tumor-infiltrating lymphocytes in primary breast cancer and metastasis","volume":"32","author":"Lee","year":"2019","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.thorsurg.2024.11.010_bib20","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/cas.13101","article-title":"Comparison of tumor-infiltrating lymphocytes between primary and metastatic tumors in breast cancer patients","volume":"107","author":"Ogiya","year":"2016","journal-title":"Cancer Sci"},{"issue":"9","key":"10.1016\/j.thorsurg.2024.11.010_bib21","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/annonc\/mdz207","article-title":"Suppressed immune microenvironment and repertoire in brain metastases from patients with resected non-small-cell lung cancer","volume":"30","author":"Kudo","year":"2019","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.thorsurg.2024.11.010_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102053","article-title":"Distinct T cell receptor repertoire diversity of clinically defined high-grade serous ovarian cancer treatment subgroups","volume":"24","author":"Lee","year":"2021","journal-title":"iScience"},{"issue":"5","key":"10.1016\/j.thorsurg.2024.11.010_bib24","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/CJI.0000000000000124","article-title":"Metastatic lung lesions as a preferred resection site for immunotherapy with tumor infiltrating lymphocytes","volume":"39","author":"Ben-Avi","year":"2016","journal-title":"J. Immunother"},{"issue":"9","key":"10.1016\/j.thorsurg.2024.11.010_bib25","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.21873\/anticanres.13689","article-title":"Tissue harvesting for adoptive tumor infiltrating lymphocyte therapy in metastatic melanoma","volume":"39","author":"Zippel","year":"2019","journal-title":"Anticancer Res"},{"key":"10.1016\/j.thorsurg.2024.11.010_bib26","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.3389\/fimmu.2020.01280","article-title":"Cancer stem cells\u2014origins and biomarkers: perspectives for targeted personalized therapies","volume":"11","author":"Walcher","year":"2020","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.thorsurg.2024.11.010_bib27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1378\/chest.59.4.383","article-title":"Clinical course related to preoperative and postoperative pulmonary function in patients with bronchogenic carcinoma","volume":"59","author":"Boushy","year":"1971","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.thorsurg.2024.11.010_bib28","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1164\/arrd.1982.125.5.604","article-title":"Exercise testing in evaluation of patients for lung resection","volume":"125","author":"Colman","year":"1982","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"10.1016\/j.thorsurg.2024.11.010_bib29","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0003-4975(10)60065-3","article-title":"Elective pulmonary lobectomy: factors associated with morbidity and operative mortality","volume":"40","author":"Keagy","year":"1985","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.thorsurg.2024.11.010_bib30","first-page":"813","article-title":"Relationship between preoperative pulmonary function tests and complications after thoracotomy","volume":"152","author":"Boysen","year":"1981","journal-title":"Surg Gynecol Obstet"},{"issue":"6","key":"10.1016\/j.thorsurg.2024.11.010_bib31","first-page":"893","article-title":"Pulmonary function test criteria for operability and pulmonary resection","volume":"153","author":"Miller","year":"1981","journal-title":"Surg Gynecol Obstet"},{"issue":"4","key":"10.1016\/j.thorsurg.2024.11.010_bib32","first-page":"379","article-title":"Pulmonary function evaluation of the lung resection candidate: a prospective study","volume":"111","author":"Olsen","year":"1975","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"10.1016\/j.thorsurg.2024.11.010_bib33","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.athoracsur.2007.12.071","article-title":"Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease","volume":"85","author":"Ferguson","year":"2008","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.thorsurg.2024.11.010_bib34","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0022-5223(19)35157-8","article-title":"Diffusing capacity predicts morbidity and mortality after pulmonary resection","volume":"96","author":"Ferguson","year":"1988","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"8","key":"10.1016\/j.thorsurg.2024.11.010_bib35","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/jso.21407","article-title":"Diffusion lung capacity for carbon monoxide (DLCO) is an independent prognostic factor for long-term survival after curative lung resection for cancer","volume":"100","author":"Liptay","year":"2009","journal-title":"J\u00a0Surg Oncol"},{"issue":"5 Suppl","key":"10.1016\/j.thorsurg.2024.11.010_bib36","doi-asserted-by":"crossref","first-page":"e166S","DOI":"10.1378\/chest.12-2395","article-title":"Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Brunelli","year":"2013","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.thorsurg.2024.11.010_bib38","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/j.jtcvs.2018.07.040","article-title":"Prediction of postoperative lung function after major lung resection for lung cancer using volumetric computed tomography","volume":"156","author":"Fern\u00e1ndez-Rodr\u00edguez","year":"2018","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"5","key":"10.1016\/j.thorsurg.2024.11.010_bib39","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3892\/etm.2012.498","article-title":"Adoptive cell therapy with autologous tumor-infiltrating lymphocytes and high-dose interleukin-2 for metastatic melanoma: the surgeon\u2019s perspective","volume":"3","author":"Zippel","year":"2012","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.thorsurg.2024.11.010_bib40","article-title":"The safety and feasibility of same-day discharge for the management of patients undergoing pulmonary lobectomy","author":"Zheng","year":"2024","journal-title":"Pulmonology"},{"journal-title":"J\u00a0Surg Oncol","article-title":"Pulmonary resection for tissue harvest in adoptive tumor-infiltrating lymphocyte therapy: safety and feasibility - corsini","year":"2021","key":"10.1016\/j.thorsurg.2024.11.010_bib41"}],"container-title":["Thoracic Surgery Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547412724001178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547412724001178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T11:38:50Z","timestamp":1750419530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547412724001178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1547412724001178"],"URL":"https:\/\/doi.org\/10.1016\/j.thorsurg.2024.11.010","relation":{},"ISSN":["1547-4127"],"issn-type":[{"type":"print","value":"1547-4127"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Metastasectomy for Tissue Acquisition for Tumor-Infiltrating Lymphocyte Harvest and Biomarker\/Genomic Testing","name":"articletitle","label":"Article Title"},{"value":"Thoracic Surgery Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thorsurg.2024.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}